Medtronic PLC - Asset Resilience Ratio
Medtronic PLC (2M6) has an Asset Resilience Ratio of 7.91% as of January 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Medtronic PLC total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Medtronic PLC's Asset Resilience Ratio has changed over time. See Medtronic PLC book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Medtronic PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Medtronic PLC (2M6) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €7.24 Billion | 7.91% |
| Total Liquid Assets | €7.24 Billion | 7.91% |
Asset Resilience Insights
- Limited Liquidity: Medtronic PLC maintains only 7.91% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medtronic PLC Industry Peers by Asset Resilience Ratio
Compare Medtronic PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 5.46% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.66% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
Annual Asset Resilience Ratio for Medtronic PLC (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Medtronic PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-04-30 | 7.36% | €6.75 Billion ≈ $7.89 Billion |
€91.68 Billion ≈ $107.18 Billion |
-0.11pp |
| 2024-04-30 | 7.47% | €6.72 Billion ≈ $7.86 Billion |
€89.98 Billion ≈ $105.20 Billion |
+0.41pp |
| 2023-04-30 | 7.05% | €6.42 Billion ≈ $7.50 Billion |
€90.95 Billion ≈ $106.33 Billion |
-0.48pp |
| 2022-04-30 | 7.54% | €6.86 Billion ≈ $8.02 Billion |
€90.98 Billion ≈ $106.37 Billion |
-0.22pp |
| 2021-04-30 | 7.76% | €7.22 Billion ≈ $8.45 Billion |
€93.08 Billion ≈ $108.82 Billion |
+0.25pp |
| 2020-04-30 | 7.51% | €6.81 Billion ≈ $7.96 Billion |
€90.69 Billion ≈ $106.02 Billion |
+1.43pp |
| 2019-04-30 | 6.08% | €5.46 Billion ≈ $6.38 Billion |
€89.69 Billion ≈ $104.86 Billion |
-2.19pp |
| 2018-04-30 | 8.27% | €7.56 Billion ≈ $8.84 Billion |
€91.39 Billion ≈ $106.85 Billion |
-0.49pp |
| 2017-04-30 | 8.76% | €8.74 Billion ≈ $10.22 Billion |
€99.82 Billion ≈ $116.70 Billion |
-1.05pp |
| 2016-04-30 | 9.80% | €9.76 Billion ≈ $11.41 Billion |
€99.55 Billion ≈ $116.38 Billion |
-3.92pp |
| 2015-04-30 | 13.72% | €14.64 Billion ≈ $17.11 Billion |
€106.69 Billion ≈ $124.73 Billion |
-20.12pp |
| 2014-04-30 | 33.83% | €12.84 Billion ≈ $15.01 Billion |
€37.94 Billion ≈ $44.36 Billion |
+4.84pp |
| 2013-04-30 | 28.99% | €10.09 Billion ≈ $11.79 Billion |
€34.79 Billion ≈ $40.68 Billion |
+24.93pp |
| 2012-04-30 | 4.06% | €1.34 Billion ≈ $1.57 Billion |
€33.08 Billion ≈ $38.68 Billion |
+0.62pp |
| 2011-04-30 | 3.44% | €1.05 Billion ≈ $1.22 Billion |
€30.42 Billion ≈ $35.57 Billion |
-5.02pp |
| 2010-04-30 | 8.45% | €2.38 Billion ≈ $2.78 Billion |
€28.09 Billion ≈ $32.84 Billion |
+6.74pp |
| 2009-04-30 | 1.71% | €405.00 Million ≈ $473.49 Million |
€23.66 Billion ≈ $27.66 Billion |
-0.78pp |
| 2008-04-30 | 2.49% | €553.00 Million ≈ $646.52 Million |
€22.20 Billion ≈ $25.95 Billion |
-6.85pp |
| 2007-04-30 | 9.34% | €1.82 Billion ≈ $2.13 Billion |
€19.51 Billion ≈ $22.81 Billion |
-6.46pp |
| 2006-04-30 | 15.80% | €3.11 Billion ≈ $3.63 Billion |
€19.66 Billion ≈ $22.99 Billion |
+8.82pp |
| 2005-04-30 | 6.98% | €1.16 Billion ≈ $1.36 Billion |
€16.62 Billion ≈ $19.43 Billion |
+4.61pp |
| 2004-04-30 | 2.37% | €333.80 Million ≈ $390.25 Million |
€14.11 Billion ≈ $16.50 Billion |
+2.18pp |
| 2003-04-30 | 0.18% | €22.70 Million ≈ $26.54 Million |
€12.32 Billion ≈ $14.40 Billion |
-0.94pp |
| 2002-04-30 | 1.13% | €123.00 Million ≈ $143.80 Million |
€10.90 Billion ≈ $12.75 Billion |
-1.73pp |
| 2001-04-30 | 2.86% | €201.40 Million ≈ $235.46 Million |
€7.04 Billion ≈ $8.23 Billion |
+0.93pp |
| 2000-04-30 | 1.93% | €109.70 Million ≈ $128.25 Million |
€5.67 Billion ≈ $6.63 Billion |
-- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more